EUVIMEDEUVIMED entdecken
Crossref

The Role of Micronucleus Scoring in Cervical Papanicolaou Smears

Chiranpreet Gupta, Harpal Singh, Ninder Kumar, Preet Kanwal Sibia

International Journal of Current Pharmaceutical Review and Research · 13.05.2026 · 18 (04)

DOI: 10.25258/ijcpr.18.4.231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 13.05.2026. Verfasst von Chiranpreet Gupta und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims and Objectives: 1) To evaluate micronucleus scoring in all major diagnostic categories as defined by "The Bethesda System for Reporting Cervical Cytology" 2014, including negative for intraepithelial lesions and malignancy (NILM), inflammatory, abnormal squamous cells of undetermined significance (ASC-US), abnormal squamous cells cannot exclude high-grade squamous intraepithelial lesion (ASC-H), low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL) and invasive carcinoma (IC) in cervical Pap smears. 2) To study the frequency and pattern of MN from NILM to invasive carcinoma (IC) categories in cervical Pap smears. Materials and Methods: Pathologists independently assessed 1000 conventional cervical smears stained with Papanicolaou (Pap) stain, which included unsatisfactory for evaluation (93), NILM (154), inflammatory (673), ASC-US (25), ASC-H (19), LSIL (15), HSIL (14) and IC (7). The MN score per 1000 cells was determined by counting the number of MN cells in high-power (×400) and oil immersion (×1000).

Results

The mean MN score ± standard deviation was found to be 0.99 ± 0.744 in NILM cases, 0.67 ± 0.782 in inflammatory cases, 1.57 ± 0.507 in ASC-US cases, 1.63 ± 0.50 in ASC-H cases, 1.56 ± 0.511 in LSIL cases, 2.47 ± 0.516 in HSIL cases and 3.0 ± 0.00 in IC cases. A step-wise increase was observed in MN score from inflammatory to IC categories.

Conclusions

MN score is a reliable and easy test that can be used in conjunction with routine cervical PAP to assess the risk of malignant transformation in the uterine cervix as a biomarker for predicting the risk of carcinoma.

Zitieren

APA

Gupta, C., Singh, H., Kumar, N., & Sibia, P. K. (2026). The Role of Micronucleus Scoring in Cervical Papanicolaou Smears. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.231

Vancouver

Gupta C, Singh H, Kumar N, Sibia PK. The Role of Micronucleus Scoring in Cervical Papanicolaou Smears. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.231

BibTeX
@article{Gupta2026,
  author = {Gupta, Chiranpreet and Singh, Harpal and Kumar, Ninder and Sibia, Preet Kanwal},
  title = {The Role of Micronucleus Scoring in Cervical Papanicolaou Smears},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {04},
  doi = {10.25258/ijcpr.18.4.231}
}
Kostenlos starten →